BACKGROUND: Isoflurane reduces myocardial ischemia-reperfusion injury within hours to days of reperfusion. Whether isoflurane produces sustained cardiac protection has never been examined. The authors studied isoflurane-induced cardiac protection in the intact mouse after 2 h and 2 weeks of reperfusion and determined the dependence of this protection on adenosine triphosphate-dependent potassium channels and the relevance of this protection to myocardial function and apoptosis. METHODS: Mice were randomly assigned to receive oxygen or isoflurane for 30 min with 15 min of washout. Some mice received mitochondrial (5-hydroxydecanoic acid) or sarcolemmal (HMR-1098) adenosine triphosphate-dependent potassium channel blockers with or without isoflurane. Mice were then subjected to a 30-min coronary artery occlusion followed by 2 h or 2 weeks of reperfusion. Infarct size was determined at 2 h and 2 weeks of reperfusion. Cardiac function and apoptosis were determined 2 weeks after reperfusion. RESULTS: Isoflurane did not change hemodynamics. Isoflurane reduced infarct size after reperfusion when compared with the control groups (27.7 +/- 6.3 vs. 41.7 +/- 6.4% at 2 h and 19.6 +/- 5.9 vs. 28.8 +/- 9.0% at 2 weeks). Previous administration of 5-hydroxydecanoic acid, but not HMR-1098, abolished isoflurane-induced cardiac protection. At 2 weeks, left ventricular end-diastolic diameter was decreased significantly and end-systolic pressure and maximum and minimum dP/dt were improved by isoflurane. Isoflurane-treated mice subjected to ischemia and 2 weeks of reperfusion showed less expression of proapoptotic genes, significantly decreased expression of cleaved caspase-3, and significantly decreased deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling-positive nuclei compared with the control group. CONCLUSIONS: Cardiac protection induced by isoflurane against necrotic and apoptotic cell death is associated with an acute memory period that is sustained and functionally relevant 2 weeks after ischemia-reperfusion injury in mice in vivo.
BACKGROUND:Isoflurane reduces myocardial ischemia-reperfusion injury within hours to days of reperfusion. Whether isoflurane produces sustained cardiac protection has never been examined. The authors studied isoflurane-induced cardiac protection in the intact mouse after 2 h and 2 weeks of reperfusion and determined the dependence of this protection on adenosine triphosphate-dependent potassium channels and the relevance of this protection to myocardial function and apoptosis. METHODS:Mice were randomly assigned to receive oxygen or isoflurane for 30 min with 15 min of washout. Some mice received mitochondrial (5-hydroxydecanoic acid) or sarcolemmal (HMR-1098) adenosine triphosphate-dependent potassium channel blockers with or without isoflurane. Mice were then subjected to a 30-min coronary artery occlusion followed by 2 h or 2 weeks of reperfusion. Infarct size was determined at 2 h and 2 weeks of reperfusion. Cardiac function and apoptosis were determined 2 weeks after reperfusion. RESULTS:Isoflurane did not change hemodynamics. Isoflurane reduced infarct size after reperfusion when compared with the control groups (27.7 +/- 6.3 vs. 41.7 +/- 6.4% at 2 h and 19.6 +/- 5.9 vs. 28.8 +/- 9.0% at 2 weeks). Previous administration of 5-hydroxydecanoic acid, but not HMR-1098, abolished isoflurane-induced cardiac protection. At 2 weeks, left ventricular end-diastolic diameter was decreased significantly and end-systolic pressure and maximum and minimum dP/dt were improved by isoflurane. Isoflurane-treated mice subjected to ischemia and 2 weeks of reperfusion showed less expression of proapoptotic genes, significantly decreased expression of cleaved caspase-3, and significantly decreased deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling-positive nuclei compared with the control group. CONCLUSIONS: Cardiac protection induced by isoflurane against necrotic and apoptotic cell death is associated with an acute memory period that is sustained and functionally relevant 2 weeks after ischemia-reperfusion injury in mice in vivo.
Authors: Mira Sastri; Kristofer J Haushalter; Mathivadhani Panneerselvam; Philip Chang; Heidi Fridolfsson; J Cameron Finley; Daniel Ng; Jan M Schilling; Atsushi Miyanohara; Michele E Day; Hiro Hakozaki; Susanna Petrosyan; Antonius Koller; Charles C King; Manjula Darshi; Donald K Blumenthal; Sameh Saad Ali; David M Roth; Hemal H Patel; Susan S Taylor Journal: Proc Natl Acad Sci U S A Date: 2013-01-14 Impact factor: 11.205
Authors: Mathivadhani Panneerselvam; Yasuo M Tsutsumi; Jacqueline A Bonds; Yousuke T Horikawa; Michelle Saldana; Nancy D Dalton; Brian P Head; Piyush M Patel; David M Roth; Hemal H Patel Journal: Am J Physiol Heart Circ Physiol Date: 2010-09-10 Impact factor: 4.733
Authors: Yasuo M Tsutsumi; Yoshitaka Kawaraguchi; Yousuke T Horikawa; Ingrid R Niesman; Michael W Kidd; Blake Chin-Lee; Brian P Head; Piyush M Patel; David M Roth; Hemal H Patel Journal: Anesthesiology Date: 2010-05 Impact factor: 7.892
Authors: Ning Yin; Zhendan Peng; Bin Li; Jiangyan Xia; Zhen Wang; Jing Yuan; Lei Fang; Xinjiang Lu Journal: Am J Transl Res Date: 2016-05-15 Impact factor: 4.060
Authors: Yasuo M Tsutsumi; Yousuke T Horikawa; Michelle M Jennings; Michael W Kidd; Ingrid R Niesman; Utako Yokoyama; Brian P Head; Yasuko Hagiwara; Yoshihiro Ishikawa; Atsushi Miyanohara; Piyush M Patel; Paul A Insel; Hemal H Patel; David M Roth Journal: Circulation Date: 2008-10-20 Impact factor: 29.690
Authors: Heidi N Fridolfsson; Yoshitaka Kawaraguchi; Sameh S Ali; Mathivadhani Panneerselvam; Ingrid R Niesman; J Cameron Finley; Sarah E Kellerhals; Michael Y Migita; Hideshi Okada; Ana L Moreno; Michelle Jennings; Michael W Kidd; Jacqueline A Bonds; Ravi C Balijepalli; Robert S Ross; Piyush M Patel; Atsushi Miyanohara; Qun Chen; Edward J Lesnefsky; Brian P Head; David M Roth; Paul A Insel; Hemal H Patel Journal: FASEB J Date: 2012-08-02 Impact factor: 5.191